Patents by Inventor Mats Dahlberg

Mats Dahlberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
    Publication number: 20060228778
    Abstract: The present invention relates to novel vitamin D receptor related (VDRR) polypeptides, and formulations containing the same. Nucleic acid sequences encoding the VDRR polypeptides, expression vectors containing such sequences and host cells transformed with such expression vectors are also disclosed, as are methods for the expression of the novel VDRR polypeptides of the invention. The invention further relates to VDRR polypeptides for use as medicaments, and use of substances affecting VDRR signal transduction for the manufacture of medicaments for metabolic, proliferative or inflammatory conditions. The present invention also relates to methods for identifying clones encoding a VDRR polypeptide, methods for identifying ligands to a VDRR and methods for identifying substances for treatment of conditions affected by a VDRR polypeptide.
    Type: Application
    Filed: March 6, 2006
    Publication date: October 12, 2006
    Inventors: Anders Berkenstam, Mats Dahlberg
  • Nucleic acid encoding vitamin D receptor related polypeptide
    Patent number: 7118885
    Abstract: The present invention relates to novel vitamin D receptor related (VDRR) polypeptides, and formulations containing the same. Nucleic acid sequences encoding the VDRR polypeptides, expression vectors containing such sequences and host cells transformed with such expression vectors are also disclosed, as are methods for the expression of the novel VDRR polypeptides of the invention. The invention further relates to VDRR polypeptides for use as medicaments, and use of substances affecting VDRR signal transduction for the manufacture of medicaments for treating metabolic, proliferative or inflammatory conditions. The present invention also relates to methods for identifying clones encoding a VDRR polypeptide, methods for identifying ligands to a VDRR and methods for identifying substances for treatment of conditions affected by a VDRR polypeptide.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: October 10, 2006
    Assignee: Pfizer Inc.
    Inventors: Anders Berkenstam, Mats Dahlberg
  • Human p21-activated kinase 5 polypeptide
    Patent number: 7005285
    Abstract: The present invention provides a human polypeptide homolog of P21-activated kinase (PAK) polynucleotides which identify and encode PAK5 serine/threonine kinase. In addition, the invention provides expression vectors, host cells and methods for its production. The invention also provides methods for the identification of PAK5 agonists/antagonists, useful for the treatment of human diseases and conditions.
    Type: Grant
    Filed: November 14, 2000
    Date of Patent: February 28, 2006
    Assignee: Pharmacia & Italia S.P.A.
    Inventors: Mats Dahlberg, Jurgen Moll, Arturo Galvani
  • NOVEL VITAMIN D RECEPTOR RELATED POLYPEPTIDES, NUCLEIC ACID SEQUENCE ENCODING THE SAME AND USES THEREOF
    Publication number: 20030032790
    Abstract: The present invention relates to novel vitamin D receptor related (VDRR) polypeptides, and formulations containing the same. Nucleic acid sequences encoding the VDRR polypeptides, expression vectors containing such sequences and host cells transformed with such expression vectors are also disclosed, as are methods for the expression of the novel VDRR polypeptides of the invention. The invention further relates to VDRR polypeptides for use as medicaments, and use of substances affecting VDRR signal transduction for the manufacture of medicaments for treating metabolic, proliferative or inflammatory conditions. The present invention also relates to methods for identifying clones encoding a VDRR polypeptide, methods for identifing ligands to a VDRR and methods for identifying substances for treatment of conditions affected by a VDRR polypeptide.
    Type: Application
    Filed: August 31, 1998
    Publication date: February 13, 2003
    Inventors: ANDERS BERKENSTAM, MATS DAHLBERG